We are live on
!
Find out more
BIA
Biondo Investment Advisors Portfolio holdings
AUM
$780M
1-Year Est. Return
21.03%
This Fund
S&P 500
This Quarter
Est. Return
+18%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.37%
AUM
$433M
AUM Growth
+$42.1M
(+11%)
Cap. Flow
-$5.9M
Cap. Flow
% of AUM
-1.36%
Top 10 Holdings %
Top 10 Hldgs %
49.51%
Holding
92
New
6
Increased
40
Reduced
31
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$3.04M |
| 2 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$3.02M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$2.9M |
| 4 |
AMRN
Amarin Corp
AMRN
|
+$2.43M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$5.62M |
| 2 |
Align Technology
ALGN
|
+$5.05M |
| 3 |
Twilio
TWLO
|
+$2.5M |
| 4 |
DuPont de Nemours
DD
|
+$1.79M |
| 5 |
Lockheed Martin
LMT
|
+$1.61M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.21% |
| 2 | Technology | 16.83% |
| 3 | Financials | 13.03% |
| 4 | Consumer Discretionary | 7.41% |
| 5 | Communication Services | 6.53% |
Similar funds
LA
UBV
SG
RTM
TCMX
QCMNJ
TIS
MO
Biondo Investment Advisors's Q4 2019 Portfolio in Review
As of Q4 2019, Biondo Investment Advisors held 92 positions worth $433M, up 11% from $391M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Biondo Investment Advisors's Q4 2019 filing shows 6 new, 40 increased, 31 reduced and 5 closed positions. Its largest new stake was State Street Health Care Select Sector SPDR ETF: 15,025 shares worth $1.53M. The largest sale was Intel, an estimated $5.62M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 34% a quarter earlier, followed by Technology and Financials.
- Biondo Investment Advisors's largest Q4 2019 buy was State Street Health Care Select Sector SPDR ETF: 15,025 shares worth $1.53M.
- Biondo Investment Advisors added most to Vertex Pharmaceuticals in Q4 2019, an estimated $3.04M increase.
- Biondo Investment Advisors's biggest Q4 2019 reduction was Align Technology, cutting an estimated $5.05M.
- Biondo Investment Advisors fully exited Intel in Q4 2019, selling an estimated $5.62M.
- Biondo Investment Advisors's ten largest holdings make up 50% of its $433M portfolio in Q4 2019.
- Biondo Investment Advisors opened 6 new positions and closed 5 in Q4 2019.
- Biondo Investment Advisors's portfolio value rose 11% quarter-over-quarter to $433M.
Based on Biondo Investment Advisors's 13F filing for Q4 2019, filed 6 Feb 2020.